The major histocompatibility complex class II molecules, like the immunoglobulins, are prominent B-lymphocyte markers. Herein, we describe a B-cell-specific enhancer associated with the murine class H gene, E'. This enhancer has a complex anatomy that suggests interactions between remotely spaced elements. Of particular interest is the finding that two CCAAT boxes spaced one kilobase apart are important for enhancer activity. Somewhat surprisingly, the E. and immunoglobulin enhancers seem to show little resemblance.
Many eucaryotic genes rely on enhancer elements for high-level expression (for reviews, see 16, 25 ; A. K. Hatzopoulos, U. Schlokat, and P. Gruss, in B. D. Hames and D. M. Glover, ed., Eukaryotic RNA Synthesis and Processing, in press; B. Wasylyk, Biochim. Biophys. Acta, in press). These constitute a rather diverse class of regulatory elements differing significantly in the magnitude, specificity, and reach of their stimulatory activity. Some enhancers are capable of increasing transcription a fewfold, others, a few hundredfold. Enhancers can occur in association with genes that are ubiquitously expressed or with loci that are transcribed under strict cell-type-specific control. They may act constitutively or may show inducible or repressible activity. Enhancers can reside within the 5'-flanking region, the 3'-flanking region, or even within the transcribed portion of a gene. They may be capable of stimulating transcription from an RNA initiation site located kilobases (kb) away or may operate efficiently only when closely juxtaposed to the start site.
Probably the best characterized cell-type-specific enhancers are those associated with the heavy (p) and light (K) chain immunoglobulin loci (for reviews and references, see 1, 6, 16 ; Hatzopoulos, Schlokat, and Gruss, in press). These elements are largely responsible for the marked B-cell specificity of immunoglobulin gene transcription. The ,u and K enhancers are both located within an intron that is brought near the normal RNA initiation site only after locus rearrangement during differentiation. Both consist of multiple 6-to 12-base-pair (bp) motifs that are recognized by sequencespecific DNA-binding proteins: the octamer motif, multiple Ephrussi sequences, and the NF-KB binding site. The different motifs exert diverse influences on transcription; some enhance constitutively (the octamer [5, 7, 15, 33] ), some appear to be inducible (the NF-KB site [15, 22] ), and others appear to repress (,uE2 [10, 31] ). Interplay between the motifs, or more accurately, between the proteins that bind to them, results in a strong B-cell-specific stimulatory activity. The p. and K elements have served as prototypes for the cell-type-specific enhancer in general and for the B-cellspecific enhancer in particular. But it is not known whether enhancers associated with other B-cell-restricted genes fit this prototype. Next to the immunoglobulins, the most prominent set of B-cell surface proteins are the major histocompatibility * Corresponding author. complex (MHC) class II molecules. The precise pattern of immunoglobulin and class II molecule expression within the B-lymphocyte lineage does differ, however (for reviews, see 6, 27) . The latter are displayed prominently on B cells but are generally absent from the surface of immature pre-B and terminally differentiated plasma cells. In addition, class II antigens can be found on a few non-B cells that do not express immunoglobulin, most notably macrophages, interdigitating (dendritic) cells, and thymic epithelial cells. Finally, the MHC class II and immunoglobulin genes respond differentially to a variety of effectors, e.g., lipopolysaccharide, gamma interferon, and interleukin-4.
Because of these similarities and differences, we set out to compare the mechanisms that control immunoglobulin and MHC class II gene expression. In this report, we describe a B-cell-specific enhancer located in the 5'-flanking region of the murine class II gene, E,. This enhancer has a complex and interesting anatomy which suggests interplay between widely spaced DNA sequence motifs. Surprisingly, there seems to be little resemblance between the E. and immunoglobulin gene enhancers.
MATERIALS AND METHODS
Cells. The cells used in this study were: M12, WEHI 231, and A20 (murine B-lymphoma lines); PD31 and 18.81 (murine pre-B lines); AG501.X63 (a murine plasmacytoma line referred to in the text and figures as X63); BW5147 (a murine T-lymphoma line); and NIH 3T3 and LMTK (murine fibroblast lines). All cell lines were grown in Dulbecco medium supplemented with 10% fetal calf serum. A20, PD31, and 18.81 cells were grown in the presence of 50 p.M 2-mercaptoethanol.
Plasmids. The control plasmids pAO and pAlOl were obtained from M. Zenke and P. Chambon (34) (1, 162 bp) with the ScaI-BamHI fragment of pBR322 (890 bp). (x) pSD2121, pSD2122, and pSD2123 carry the X', Y', and W deletions (respectively) on a pSD212 background. They were created by oligonucleotide-directed mutagenesis as above, but were recloned into pAlOl rather than pS3. (xi) pl, p21, and pSph were derived from pSD212 by religation after cutting with AatII, AatII-SalI, and AatII-SphI. Thus, their 5' endpoints are -1760, -1663, and -1214, respectively. (xii) p24, p16, p49, p37, p22, p59, and p69 also derive from pSD212. Progressive 5'-end deletions were created by cutting with AatII-SalI, digesting with exonuclease III for increasing times, treating with mung bean nuclease, and religating. (xiii) pSD221, pSD222, and pSD223 were derived from pS3 by deletion of the SphI-BamHI, KpnI-BamHI, and Sall-BamHI fragments. Thus, their 3' endpoints are -1214, -1322, and -1663, respectively.
Transfections. DNA was transfected into tissue culture cells by using the DEAE-dextran protocol of McCutchan and Pagano (18) .
For lines M12, A20, NIH 3T3, and LMTK (which remain attached to the culture dish throughout the transfection and washing procedures) 2 x 106 cells were seeded onto 10-cm dishes 24 h prior to transfection in 10 ml of medium-10% fetal calf serum (FCS). Just prior to transfection, the medium was removed, and the cells were washed once with 5 ml of serum-free medium. The cells were then incubated in 800 ,u1 of transfection mix (serum-free medium containing 10 ,ug of plasmid DNA and 0.25 mg of DEAE-dextran per ml) for exactly 5 min at 25°C. The incubation was stopped by removing the transfection mix and washing the cells with 5 ml of medium-10% FCS. Finally, the cells were incubated with 15 (4, 14, 30, 32) .
Moreover, when the -2,172 to +12 fragment of the E, gene is ligated to a reporter gene, this chimeric construct can also be effectively transcribed in transgenic-mouse B cells (H. J. Fehling et al., manuscript in preparation). Hence, in our search for B-cell-specific enhancer activity associated with the E. locus, we have concentrated on the -2,172 to +12 region.
Our strategy had been to measure the capacity of various fragments in this region to activate transcription from a heterologous promoter. We have taken a reductionist view of the definition of an enhancer, deemphasizing the importance of activity at a distance and activity in both orientations. This view is in line with contemporary opinion that enhancers constitute a diverse set of regulatory elements with a spectrum of properties and that enhancers are not really fundamentally different from upstream regulatory elements (16, 25) . Figure 1 
Promoter: Enhancer-less SV40 early pAO 101
Reporter: Rabbit B-globin coding region cell line: types and thus serves as a negative control. A plasmid bearing the SV40 enhancer (pAO) is quite efficiently transcribed in most cell types and can be used as a positive control. As an initial test of E. enhancer activity, we created a plasmid (pS3) carrying the -2172 to + 12 fragment. pAlOl, pAO, and pS3 were individually transfected into several lymphoid and nonlymphoid cell lines, and transcription from each construct was evaluated 48 h later by quantitative Si nuclease mapping of cytoplasmic RNA. All of the experiments were repeated at least three times with at least two independent plasmid preparations.
As shown in Fig. 1 , the enhancerless plasmid is not expressed or is only very feebly expressed in all cell lines tested (center lanes of each panel). In contrast, the SV40 enhancer greatly activates transcription in all the lines (left lanes of each panel). The variable degree of activation reflects some true differences in SV40 enhancer function as well as a repeatable variation in transfection efficiency of the different cell lines. The 2-kb E,,, fragment clearly shows enhancer activity but only in B cells that normally express MHC class II genes: M12, WEHI 231, and A20. This B-cell-specific stimulatory activity is quite potent, ranging from as strong as that of the SV40 enhancer in M12 and WEHI 231 cells to about 20% as strong as that in A20 cells. around in pSD212 and pSD213, both constructs are efficiently transcribed in B-lymphoma cells (data not shown).
The ubiquitous activity of the promoter-distal enhancer is somewhat surprising. One possible explanation is that in our enhancer test construct this element was brought in close proximity to the promoter and ubiquitously acting motifs which could not exert their influence over long distances now functioned efficiently. To address this possibility, we created a plasmid (pSD312) that has 890 bp of pBR322 sequences (ScaI3846 -BamHI375) inserted into pSD212 between the Er,, -2172 to -1148 fragment and the SV40 promoter. This construct was as actively transcribed as pSD212 in the mature B cells M12 and A20 but showed no transcription in the non-B cells BW5147 and X63 (data not shown). Apparently then, the cell-type nonspecific transcription of pSD212 is caused by the juxtaposition of the distal element with the promoter.
Because of sequence considerations (see below), we suspected that the promoter-proximal enhancer actually resides on the -215 to +12 fragment. To test this proposition, we cloned the -1148 to -215 and -215 to +12 fragments into the enhancer test construct to create plasmids pSD216 and pX3. As illustrated in Fig. 2 , the former is not detectably transcribed in any cell line tested (lane d); the latter is transcribed almost as effectively as pSD213 (carrying the entire 1-kb promoter-proximal fragment) in all three B-cell lines (compare lanes c and e of each panel).
We conclude then that the E, enhancer is bipartite; there is a B-cell-specific element in the -215 to +12 region and another element on the -2172 to -1148 fragment that is B-cell specific in its proper context but that acts ubiquitously when brought close to the promoter. (4) . In addition, both motifs serve as recognition sites for sequence-specific DNAbinding proteins (3, 4, 11, 19) . Of particular interest is the finding that Y actually includes a CCAAT box and is recognized by a CCAAT-box-binding protein.
On the basis of these considerations, we constructed plasmids pXD21 and pXD301 (carrying clean deletions of the X and Y boxes) and transfected them into the B-cell line M12. Transcription from each construct was compared with that from pX3 (positive standard) and pAlOl (negative standard). Neither pXD21 nor pXD301 was transcribed above background levels (Fig. 3) . The same result was obtained with pXD10, which bears a deletion of X, Y, and the sequences between. To rule out the possibility that the deletions are detrimental because they interfere with spacing rather than because they eliminate a particular DNA sequence, we made and tested pXXC and pXYC, which carry random sequences replacing the X and Y boxes. SV40 promoter. This point is best substantiated by comparing the pX26 and pX3 values in Fig. 3 .
All of the aforementioned constructs were also transfected into the T hybridoma BW5147, which does not support the stimulatory activity of the intact -215 to + 12 fragment. This experiment was aimed at detecting enhancer activity that might be uncovered by removal of a repressor sequence. Since none of the plasmids are transcribed above background levels in BW5147 (or in X63, data not shown), we surmise that the promoter-proximal 230-bp stretch does not carry a repressor of activity in non-B cells.
In summary, the X and Y boxes are crucial determinants of the B-cell-specific enhancer activity associated with the -215 to + 12 fragment of the E,, gene. Other sequences in the region serve to optimize enhancer function. Stimhlatory activity of the -2172 to -1148 fragment dependent primarily on the W sequence. To delineate the sequence elements required for activity of the -2172 to -1148 fragment in a promoter-adjacent position, we created a series of deletions in the plasmid pSD212, which carries the -2172 to -1148 fragment. The mutant plasmids were transfected into the MHC class II-positive B-cell line M12 and into the class TI-negative plasmacytoma X63. Transcription from the mutants was compared with that from pSD212 (positive standard) and pAlOl (negative standard). The results are summarized in Fig. 4 .
The first set of mutants has progressively longer deletions proceeding in a 3' direction from position -2172. A deletion of up to 750 bp (p37) does not result in any significant loss of transcriptional activity whether assayed in M12 'or X63 cells. To support this conclusion, we created a complementary set of deletions in pSD212 that proceed in a 5' direction from position -1148. The first deletion (to position -1214) resulted in complete loss of transcriptional activity in both M12 and X63 cells (pSD221). Longer deletions did not restore transcriptional activity (pSD222 and pSD223). These results emphasize the importance of the element located between -1240 and -1190 and suggest that the secondary element between positions -1420 and -1300 cannot act autonomously.
The region between -1400 and -1150 of the E. gene contains several potentially important DNA sequence motifs (2, 4a) . Most strikingly, a second copy of the X-Y pair occurs in reverse orientation; X' and Y', as they have been termed, reside at positions -1359 to -1346 and -1392 to 1379, respectively. It may be worth noting that Y' (like Y) includes a CCAAT box. There is in addition a sequence termed W at positions -1202 to -1193 that is known to bind a B-cellspecific and ubiquitously occurring nuclear protein (2) .
To directly test the contribution of X', Y', and W to enhancer function, we made a clean deletion of each in pSD212 and measured the transcriptional activity of the mutant plasmids in M12 and X63. Deletion of the Y' box (pSD2122) had little or no effect in either cell line, while deletion of the X' box (pSD2121) resulted in a fourfold reduction of transcription in M12 but not in X63 cells. The difference between the X63 and M12 values with pSD2121 resembles that previously observed with the p22 and pSph mutants (see above). Finally, a clean deletion of the W box (pSD2123) resulted in essentially complete abrogation of enhancer activity.
Clearly then, the most critical element for the enhancer activity of the -2172 to -1148 fragment in a promoteradjacent position is the W motif. This is true whether we measure stimulation in class-II-molecule-expressing cells or in nonexpressers. The X' box seems to modulate the activity of the enhancer up to fourfold in some cell types.
Function of both the promoter-proximal and promoterdistal enhancers in the context of the -2172 to +12 fragment. Thus far, we have described the properties of the promoterproximal and promoter-distal Ea elements as they operate in isolation at a promoter-adjacent position. Obviously, it is also important to study the enhancers in context, juxtaposed on the -2172 to + 12 fragment. Hence, we created a series of pS3-based plasmids that bear single-or double-motif deletions. The mutant plasmids were transfected into M12 and X63 cells, and transcription from each compared with that from pS3 (positive standard) and pA101 (negative standard).
Both the promoter-distal and promoter-proximal elements function in the context of the -2172 to +12 fragment (Fig.  5) . Deletions of the X or Y box destroy the stimulatory activity of the -215 to + 12 fragment in isolation (Fig. 3) , but in the context of the entire 2-kb fragment they result in only a two-or threefold reduction in stimulation (Fig. 5, pSD21 and pSD302). Similarly, deletion of the W motif would critically impede activity of the -2172 to -1148 fragment in isolation (Fig. 4) , but in the context of the 2-kb fragment it has essentially no effect on stimulatory capacity (Fig. 5,  pSD33 ). X' and Y' deletions are also incapable of abolishing the activity of the -2172 to +12 fragment (Fig. 5, pSD31 and  pSD32 ).
In addition, the enhancer activity displayed by the 2-kb fragment is not the simple sum of its two halves (Fig. 5) . Two points are most illustrative. (i) A deletion of X or Y in the -215 to +12 fragment or a deletion of W in the -2172 to -1148 fragment abolishes the enhancer activity of both moieties ( Fig. 3 and 4 ). Yet the double deletions X+W and Y+W in the -2172 to +12 fragment result in only a three-to fivefold reduction in transcription levels (Fig. 5). (ii) A deletion of Y' in the -2172 to -1148 fragment has little effect on stimulatory activity, appearing much less detrimental than an X' or W deletion (Fig. 4) . But in the context of the entire 2-kb fragment, a Y' mutation is more drastic than either an X' or W mutation (Fig. 5) . This is true with both single and double deletions (compare pSD32 with pSD31 and pSD33 or pSD302/32 with pSD302/33). Comparison of pSD302 with pSD302/33 and pSD21 with pSD21/33 or pSD21/31 indicates that X' and W still play some role, however.
These discrepancies could reflect the fact that in the context of the entire 2-kb fragment, a particular sequence motif has the opportunity to interact with both adjacent and remote companion motifs. Alternatively, different motifs in the promoter-distal element may take precedence when it is MOL. CELL. BIOL. The plasmids were transfected into M12 (B-cell) and X63 (plasmacytoma cell) lines. RNA was isolated after two days, and transcription initiated from the SV40 promoter was quantitated by S1 nuclease mapping. The values obtained for specific RNA transcribed from the constructs in M12 cells were related to the value obtained from cells transfected with pS3, which was set to 100%o. In X63 cells, only very little activity was observed, and none of the constructs exhibited any activity over that detected with the enhancerless plasmid pAlOl. The quantitations are based on three (M12) or two (X63) independent experiments with two different plasmid preparations. Standard errors ± 15% of the means. located hundreds of bases away from the SV40 promoter. Motif deletions in the construct which intercalates pBR322 sequences between the E,,, enhancer and the SV40 promoter (pSD312) should resolve this issue.
NEW B-CELL-SPECIFIC ENHANCER
It may be worth pointing out that all of the stimulatory activity displayed by the -2172 to +12 fragment, whether attributable to the promoter-proximal or promoter-distal component, is B cell specific. None of the mutants are transcribed above background levels in either X63 or BW5147 cells ( Fig. 5 ; data not shown).
From these results, we conclude that both halves of the -2172 to +12 fragment contribute to its B-cell-specific enhancer activity. Yet, the compound enhancer is not the simple sum of its two components. DISCUSSION B-cell-specific enhancer. The murine Ea gene, like other MHC class II loci, is transcribed constitutively in mature B cells. As far as is known, this is the only cell type in mice that shows constitutive expression of class II genes. In this report, we describe an enhancer that no doubt contributes to the transcriptional activity of the Eat gene in B cells. The enhancer extends over a 2-kb stretch at the 5' end of the gene and has a complex anatomy. There is a promoter-proximal element that is B cell specific and relies principally on the conserved X and Y sequences. There is also a promoterdistal element that is B cell specific when located at a distance from the promoter but is ubiquitously acting in a promoter-adjacent position. The activity of this element depends on the X', Y', and W sequences, with their relative contributions differing greatly according to the context of the element.
So far, the cell-type specificity of the E. enhancer correlates perfectly with expression of the endogenous class II genes; it is active in several mature B-cell lines but not in pre-B or plasmacytoma cells nor in several nonlymphoid class II-negative cell lines. We do not know yet whether the activity of this enhancer is restricted purely to B cells or if it will prove operative in other cells that express Ea, in particular in gamma-interferon-inducible cells. (Preliminary results do suggest that it is inactive in thymic epithelial cells).
An enhancer with a few of these features has recently been described (28) . A 1.8-kb fragment at the 5' end of the human class II gene DQa is capable of stimulating transcription from the thymidine kinase promoter. The stimulatory activity also centered around the X and Y boxes. The DQa enhancer seems similar to the E. promoter-proximal element although we do not have information on its cell-type specificity. We are also ignorant of whether the DQa gene carries an element analogous to the Ea promoter-distal element.
Our findings should be considered in conjunction with two results obtained with transgenic mice. First, mouse cells carrying an Ea gene with a clean deletion of either the X or Y box still express E., mRNA in a cell-type-specific fashion (4) . But the transcripts are less abundant than with the wild-type gene and are initiated at multiple sites as far upstream as the X'-Y' region. This phenotype could occur if the X and Y deletions abrogate promoter-proximal enhancer activity, leaving transcription to be stimulated (less efficiently) by the promoter-distal element. It would thus be similar to the phenotype displayed by the pSD21 and pSD302 constructs (Fig. 5) . The fact that aberrant initiation does not occur on pSD21 and pSD302 (data not shown) may be attributable to the strong influence of the SV40 promoter.
Second, mouse cells that carry an E. gene with only 1,180 bp of 5'-flanking sequence fail to express E,, mRNA in B lymphocytes although not in other class II-positive cells (e.g., gamma-interferon-treated macrophages) (4a, 30, 32) .
This result appears inconsistent with the observation that the -1180 to + 12 fragment shows significant B-cell-specific enhancer activity in transfection experiments (Fig. 2) . The discrepancy is probably related to the different assay sys- The promoter-proximal enhancer depends primarily on the X and Y boxes; nuclear proteins that specifically recognize these sequences have recently been described. NF-Y is a large (200-to 300-kilodalton) complex that binds to the Y box (3, 4, 9, 11, 19, 26) . It is, in fact, a CCAAT-box-binding protein and, as such, occurs in all cell types (3, 9) . NF-X appears to be an even larger complex that binds to the X box (4, 11, 19) . It is also detected in all cell types so far examined.
The promoter-distal enhancer depends variably on the X', Y', and W boxes, depending on its context with respect to the promoter. It has been demonstrated quite clearly that X' and Y' are recognized by NF-X and NF-Y just as the promoter-proximal X and Y are (4a). The W motif binds at least two nuclear proteins (termed NF-W1 and NF-W2) characterized in detail elsewhere (2) .
These results have several interesting implications that require further investigation. (i) Y is critical for enhancer activity of the promoter-proximal element (Fig. 3, pXD301 ) and Y' is crucial for promoter-distal enhancer function (Fig.  5 , cf. pSD302 and pSD302/32). Both sequences contain a CCAAT box and are recognized by the CCAAT-box-binding protein, NF-Y. As far as we know, this represents the first functional evidence that a CCAAT box is implicated in enhancer activity. This would indicate a potential analogous to that displayed by the immunoglobulin octamer (ATTTG CAT) known to function as both a promoter and enhancer element (16) . One should also bear in mind the binding duality of CBP/EBP, which recognizes CCAAT boxes as well as elements in the SV40 and possibly immunoglobulin enhancers (13, 21) . These observations support the notion that promoter and enhancer elements may not be fundamentally different (16, 25) . (ii) The W motif is recognized by both a B-cell-specific and ubiquitous nuclear protein (2) . NF-W1 and NF-W2 have different affinities for and make distinct contacts on the recognition sequence. In theory, they could also interact differentially with other regulatory proteins involved in E. expression. We suggest that the ability of the promoter-distal enhancer to act ubiquitously or with B-cell specificity might depend on which of these proteins is bound.
Model. The placement and orientation of the X-Y and X'-Y' homologs and the sensitivity of the promoter-distal element to its position prompts us to propose the model illustrated in Fig. 6 . The essential feature of the model is a dimerization of the proteins binding to X and X' and Y and Y', or both, resulting in a loop-out of the intervening DNA and a rapprochement of the promoter-proximal and promoter-distal regions and consequently of any proteins binding to them. Thus, for example, NF-W1 and NF-W2 might be brought into contact with RNA polymerase at the RNA initiation site.
At least two observations are consistent with this model. First, the distance but not the sequence between the X and Y boxes is conserved among all MHC class II genes, and this distance is also precisely conserved between all X' and Y' boxes (4a). Second, X and X' bind the same protein, as do Y and Y', suggesting a possibility for the formation of homodimers. Indeed, preliminary cross-linking studies suggest that purified NF-Y can form homodimers (X.-J. Li and R. Hooft van Huijsduijnen, unpublished data). However, no experimental evidence exists yet to support the model. If the E. enhancer proves to rely on a looping mechanism, it will be reminiscent of other procaryotic (8, 12, 17, 20) and eucaryotic (29) regulatory elements. That such a mechanism may be used generally for gene regulation has been discussed at length (23, 24) . E. and immunoglobulin enhancers. One goal of these studies was to compare the mechanisms controlling immunoglobulin and MHC class II gene expression in B cells. Both gene classes seem to rely on a strong cell-type-specific enhancer, but there are two striking dissimilarities. First of all, the B-lineage cells that support immunoglobulin and Ea enhancer activity differ markedly. Immunoglobulin enhancers can function in pre-B, mature B, and plasma cells (although the K enhancer is active only in the latter two); the E. enhancer operates only in mature B-cell lines. Second, the sequence motifs and consequently the DNA-binding proteins implicated in enhancer function seem to be quite distinct. The immunoglobulin enhancers are composed of multiple stimulatory 6-to 12-bp motifs, most notably the octamer motif, the NF-KB binding site, and the Ephrussi sequences. As discussed elsewhere (4a), the -2172 to +12
Ec fragment carries a sequence (positions -1703 to -1693) that is highly homologous to the NF-KB binding site on the immunoglobulin K enhancer as well as multiple Ephrussi-like sequences (positions -1821 to -1807, -1758 to -1744, and -1546 to -1532). There is no stretch with a perfect match to the immunoglobulin octamer motif on this fragment, but there is one with a single-base mismatch (position -1917 to -1910). That none of these sequences play a significant role in Ea enhancer function is evidenced by results from several constructs presented in Fig. 4 and 5. Conversely, the E, enhancer depends on multiple short DNA segments (X, Y, X', Y', W), and none of these has been detected along the immunoglobulin enhancers. In addition, competition experiments show that the proteins binding to these E, motifs are distinct from those that recognize immunoglobulin motifs (2).
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We are led to conclude, then, that immunoglobulin and MHC class II enhancers rely on largely independent mechanisms to achieve B-cell specificity.
